drugset / Trial / NCT00620737
Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety profile and the treatment effect of Isolagen TherapyTM and placebo when administered to stable restrictive burn scars of an affected joint area.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-12
- Completion
- —
Outcome
Outcome not reported
Stopped: “Company Decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isolagen TherapyTM | Cell therapy | — | — |
Indications
No indication recorded.